Inventors: Swati Biswas, Sanhita Roy and Balaram Ghosh

The study focuses on developing a D-bioprinted contact lens that incorporates the host-defense peptide S100A12 for precision medicine in treating bacterial keratitis. This innovative contact lens is designed to deliver the peptide directly to the eye, targeting bacterial infections with high specificity. The research aims to enhance the therapeutic effectiveness of S100A12 by embedding it within a bioprinted contact lens, providing localized and sustained antimicrobial action. This approach represents a significant advancement in personalized ophthalmic treatment, aiming to improve outcomes for patients with bacterial keratitis through targeted, peptide-based therapy. (Pharmacy)